Binax, Inc. Announces FDA 510k Clearance Of NOW Influenza A & B Rapid Test For Identification And Differentiation between Flu A And Flu B On One Simple Test
10/19/2005 5:11:59 PM
Binax, Inc., a leading developer of rapid diagnostic tests, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the NOW(R) Influenza A & B test. This latest test from Binax replaces two individual tests, NOW Flu A and NOW Flu B, and complements the company's portfolio of diagnostic tests for respiratory tract infections.
comments powered by